The increasing fraction of low-solubility compounds in drug discovery has necessitated routine use of enabling technologies to improve oral drug absorption and bioavailability. However, choice of the best enabling technology can be challenging. Lonza employs a proven design and development roadmap based on extensive experience in bioavailability enhancement with a wide range of compounds. To learn more, please refer to our technical brief.
View our technical brief

Download now
Latest content
Latest briefing from the Knowledge Center